Earnings Feed
Sign Up
Home/Insiders/GAMZU ELKAN R
GE
SEC Insider//CIK 0001235440

GAMZU ELKAN R

CIK 00012354402 companiesLEXINGTON, MA
SEC Profile

Transactions

34

Companies

2

Filings

4

CIK

0001235440

Recent Transactions

34 trades
  • Award
    EPIX Pharmaceuticals, Inc.

    Stock Option (Right to Buy)

    2009-04-30+400,000→ 400,000 total
  • Award
    EPIX Pharmaceuticals, Inc.

    Stock Option (Right to Buy)

    2009-04-30+400,000→ 400,000 total
  • Purchase
    PHARMOS CORP

    Common Stock

    2005-06-21$2.54/sh+2,000→ 2,000 total
  • Purchase
    PHARMOS CORP

    Common Stock

    2005-06-21$2.54/sh+2,000→ 2,000 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-12-01−1,250→ 6,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-12-01$1.88/sh+1,250→ 2,500 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-12-01$3.95/sh−2,500→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-12-01−1,250→ 10,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-12-01$1.02/sh+1,250→ 1,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-12-01−1,250→ 6,250 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-12-01$3.95/sh−2,500→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-12-01$1.02/sh+1,250→ 1,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-12-01−1,250→ 10,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-12-01$1.88/sh+1,250→ 2,500 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-08-17−1,250→ 11,500 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-08-17$3.45/sh−100→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-08-17−1,250→ 11,500 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-08-17$3.43/sh−1,150→ 100 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-08-17$3.45/sh−100→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-08-17$1.02/sh+1,250→ 1,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-08-17$1.02/sh+1,250→ 1,250 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-08-17$3.43/sh−1,150→ 100 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-06-17$1.88/sh+1,250→ 1,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-06-17−1,250→ 18,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-06-17$3.88/sh−1,250→ 0 total
  • Exercise/Conversion
    PHARMOS CORP

    Common Stock

    2004-06-17$1.88/sh+1,250→ 1,250 total
  • Exercise/Conversion
    PHARMOS CORP

    Stock Options

    2004-06-17−1,250→ 18,750 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-06-17$3.88/sh−1,250→ 0 total
  • Exercise of In-Money
    PHARMOS CORP

    Stock Options

    2004-04-15−2,500→ 17,500 total
  • Exercise of In-Money
    PHARMOS CORP

    Common Stock

    2004-04-15$1.02/sh+2,500→ 2,500 total
  • Exercise of In-Money
    PHARMOS CORP

    Common Stock

    2004-04-15$1.02/sh+2,500→ 2,500 total
  • Exercise of In-Money
    PHARMOS CORP

    Stock Options

    2004-04-15−2,500→ 17,500 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-04-15$3.93/sh−2,500→ 0 total
  • Sale
    PHARMOS CORP

    Common Stock

    2004-04-15$3.93/sh−2,500→ 0 total

Companies

2

Recent Filings

4

Address

C/O EPIX PHARMACEUTICALS, INC. 4 MAGUIRE ROAD

LEXINGTON, MA, 02421

View on SEC.gov